Meta-analysis of gabapentin in the treatment of postherpetic neuralgia

Chinese Journal of Contemporary Neurology and Neurosurgery

Volumn 13, Issue 9, 2013, Pages 760-765

  Zhang, Wen Wu ^a   Li, Meng Qiu ^a   Liu, Ling ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Gamma aminobutyric acid; Metaanalysis; Neuralgia, postherpetic; Pain measurement

Indexed keywords

GABAPENTIN; PLACEBO;

ARTICLE; CLINICAL EVALUATION; DIZZINESS; DRUG EFFECT; DRUG TOLERABILITY; HUMAN; MCGILL PAIN QUESTIONNAIRE; META ANALYSIS; PAIN; PAIN ASSESSMENT; PERIPHERAL EDEMA; POSTHERPETIC NEURALGIA; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL (TOPIC); SOMNOLENCE; VISUAL ANALOG SCALE;

EID: 84889024536     PISSN: 16726731     EISSN: None     Source Type: Journal    
DOI: 10.3969/j.issn.1672-6731.2013.09.006     Document Type: Article

References (17)

1. Dworkin R H, O'Connor A B, Backonja M, Farrar J T, Finnerup N B, Jensen T S, Kalso E A, Loeser J D, Miaskowski C, Nurmikko T J, Portenoy R K, Rice A S, Stacey B R, Treede R D, Turk D C, Wallace M S. Pharmacologic management of neuropathic pain: evidence-based recommendations. Pain, 2007, 132: 237-251.
2. Jensen T S, Madsen C S, Finnerup N B. Pharmacology and treatment of neuropathic pains. Curr Opin Neurol, 2009, 22: 467-474.
3. Attal N, Cruccu G, Haanpää M, Hansson P, Jensen T S, Nurmikko T, Sampaio C, Sindrup S, Wiffen P, EFNS Task Force. EFNS guidelines on pharmacological treatment of neuropathic pain. Eur J Neurol, 2006, 13: 1153-1169.
4. Taylor C P. Mechanisms of analgesia by gabapentin and pregabalin-calcium channel alpha2-delta [Cavalpha2-delta] ligands. Pain, 2009, 142: 13-16.
5. Parsons B, Tive L, Huang S. Gabapentin: a pooled analysis of adverse events from the clinical trials in patients with postherpeticneuralgia. Am J Geriatr Pharmacother, 2004, 2: 157-162.
6. Rice A S, Maton S, Postherpetic Neuralgia Study Group. Gabapentin in postherpetic neuralgia: a randomised, double blind, placebo controlled study. Pain, 2001, 94: 215-224.
7. Irving G, Jensen M, Cramer M, Wu J, Chiang Y K, Tark M, Wallace M. Efficacy and tolerability of gastric-retentive gabapentin for the treatment of postherpetic neuralgia: results of a double-blind, randomized, placebo-controlled clinical trial. Clin J Pain, 2009, 25: 185-192.
8. Wallace M S, Irving G, Cowles V E. Gabapentin extended-release tablets for the treatment of patients with postherpetic neuralgia. Clin Drug Investig, 2010, 30: 765-776.
9. Rowbotham M, Harden N, Stacey B, Bernstein P, Magnus-Miller L. Gabapentin for the treatment of postherpetic neuralgia: a randomized controlled trial. JAMA, 1998, 280: 1837-1842.
10. Backonja M M, Canafax D M, Cundy K C. Efficacy of gabapentin enacarbil vs placebo in patients with postherpetic neuralgia and a pharmacokinetic comparison with oral gabapentin. Pain Med, 2011, 12: 1098-1108.
11. Jensen M P, Chiang Y K, Wu J. Assessment of pain quality in a clinical trial of gabapentin extended release for postherpetic neuralgia. Clin J Pain, 2009, 25: 286-292.
12. Jensen M P, Hsu P H, Vanhove G F. Early pain reduction can predict treatment response: results of integrated efficacy analyses of a once-daily gastroretentive formulation of gabapentin in patients with postherpetic neuralgia. Pain Med, 2012, 13: 1059-1066.
13. Higgins J P T, Green S. Cochrane handbook for systematic reviews of interventions. Oxford: Cochrane Collaboration, 2008 [2013-07-20]. http://handbook.cochrane.org.
14. Higgins J P T, Altman D G. Assessing risk of bias in included studies. Oxford: Cochrane Collaboration, 2008[2013-07-20]. http://handbook.cochrane.org.
15. Johnson P, Becker L, Halpern R, Sweeney M. Real-world treatment of post-herpetic neuralgia with gabapentin or pregabalin. Clin Drug Investig, 2013, 33: 35-44.
16. Nalamachu S, Morley-Forster P. Diagnosing and managing postherpetic neuralgia. Drugs Aging, 2012, 29: 863-869.
17. Beal B, Moeller-Bertram T, Schilling J M, Wallace M S. Gabapentin for once-daily treatment of post-herpetic neuralgia: a review. Clin Interv Aging, 2012, 7: 249-255.